Fig. 1From: Management strategies and clinical outcomes in breast cancer patients who develop left ventricular dysfunction during trastuzumab therapyFlow chart of patients receiving adjuvant trastuzumab at BCCA from 2010 to 2013 based on the degree of left ventricular dysfunction and rate of referral to cardiologyBack to article page